The test developer's dilemma: Evaluating the balance of feasibility and empiric performance of test development techniques for repeated written assessments.
Shappell E, Wagner MJ, Bailitz J, Mead T, Ahn J, Eyre A, Maldonado N, Wallace B, Park YS.
Med Teach. 2023 Feb;45(2):187-192. doi: 10.1080/0142159X.2022.2118042. Epub 2022 Sep 6.
Getting the "balance" right in clinical trials.
Abdel Shaheed C, Blyth F, Furmage AM, Stanaway F.
BMJ. 2021 Nov 24;375:n2869. doi: 10.1136/bmj.n2869.
Pair-switching rerandomization.
Zhu K, Liu H.
Biometrics. 2023 Sep;79(3):2127-2142. doi: 10.1111/biom.13712. Epub 2022 Jul 11.
Clinical trial designs and endpoints.
Zeissler ML, Chapman R.
Handb Clin Neurol. 2024;205:123-134. doi: 10.1016/B978-0-323-90120-8.00013-7.
Simulated annealing for balancing covariates.
Baldi Antognini A, Novelli M, Zagoraiou M.
Stat Med. 2023 Apr 30;42(9):1323-1337. doi: 10.1002/sim.9672. Epub 2023 Jan 27.
How to randomize.
Vickers AJ.
J Soc Integr Oncol. 2006 Fall;4(4):194-8. doi: 10.2310/7200.2006.023.
Balancing statistical significance and clinical relevance.
Morgan CJ.
J Nucl Cardiol. 2018 Jun;25(3):707-708. doi: 10.1007/s12350-018-1267-y. Epub 2018 Apr 12.
The pursuit of balance: An overview of covariate-adaptive randomization techniques in clinical trials.
Lin Y, Zhu M, Su Z.
Contemp Clin Trials. 2015 Nov;45(Pt A):21-5. doi: 10.1016/j.cct.2015.07.011. Epub 2015 Aug 2.
Randomization: Beyond the closurization principle.
Moulton LH.
Clin Trials. 2022 Aug;19(4):396-401. doi: 10.1177/17407745221080714. Epub 2022 Mar 1.
The Importance of the Human Mass Balance Study in Regulatory Submissions.
Coppola P, Andersson A, Cole S.
CPT Pharmacometrics Syst Pharmacol. 2019 Nov;8(11):792-804. doi: 10.1002/psp4.12466. Epub 2019 Oct 25.
